On July 27, 2022, Friends of Cancer Research hosted a webinar for patient advocates to focus on the organization’s recent work around the use of circulating tumor DNA, or ctDNA, as an early endpoint to measure treatment response.

The webinar featured researchers and experts from the FDA, patient advocacy, and academic centers as they discussed ctDNA as a biomarker that can improve patient care. Click below to watch the full webinar.